Outcomes | IF group (n = 120) | LCHA group (n = 121) | p.overall |
---|---|---|---|
Number transfused intraop(n, transfusion rate, %) | 55 (45.8%) | 63 (52.1%) | 0.333a |
Transfusion rate 1 d postop, n (%) | 15 (12.5%) | 10 (8.3%) | 0.281a |
Value transfused RBC units (for those transfused), median (IQR) | 1.5 (0, 2) | 1.5 (0, 2) | 0.822b |
Vloss total2d, mL, median (IQR) | 837.1(347.3, 1383.4) | 727.8 (334.7, 1075.2) | 0.138b |
Hbloss total2d, g/dL, median (IQR) | 88.8 (37.2, 123.7) | 73.6 (37.0, 104.7) | 0.144b |
Severe cement reaction, n (%) | 0 (0%) | 3 (2.5%) | 0.083a |
Implant local complicationsc, n (%) | 4 (3.3%) | 2 (1.7%) | 0.403a |
Refracture hospitalization rates, n (%) | 9 (7.5%) | 10 (8.3%) | 0.826a |
Postoperative ICU admission rate, n (%) | 1 (0.8%) | 5 (4.1%) | 0.100a |
Incidence of deep vein thrombosis in popliteal vein and aboved, n (%) | 1 (0.8%) | 1(0.8%) | 0.995a |
Follow-up period, m, median (IQR) | 20.0 (14.0, 29.0) | 24.0 (12.0, 36.0) | 0.255b |